In pancreatic ductal adenocarcinoma, CSTB competes with cystatin C (CSTC) to bind cathepsin B (CTSB), but CSTC has stronger cathepsin inhibitory activity. This evidence concerns the gene CSTB and pancreatic ductal adenocarcinoma.